Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 95 articles:
HTML format



Single Articles


    October 2021
  1. NIERENGARTEN MB
    Higher mortality risk in African American women with triple-negative breast cancer.
    Cancer. 2021;127:3712-3713.
    PubMed    


  2. WEISS MC, Hibbs JE, Buckley ME, Danese SR, et al
    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.
    Cancer. 2021 Oct 12. doi: 10.1002/cncr.33906.
    PubMed     Abstract available


  3. MURUGAPPAN MN, King-Kallimanis BL, Mangir C, Howie L, et al
    Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
    Cancer. 2021 Oct 11. doi: 10.1002/cncr.33959.
    PubMed     Abstract available


  4. JATOI I, Kunkler IH
    Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33960.
    PubMed     Abstract available


  5. SCHAPIRA L, Zheng Y, Gelber SI, Poorvu P, et al
    Trajectories of fear of cancer recurrence in young breast cancer survivors.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33921.
    PubMed     Abstract available


  6. GARCIA SF, Gray RJ, Sparano JA, Tevaarwerk AJ, et al
    Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33939.
    PubMed     Abstract available


  7. BRUNELLE CL, Ag AG
    The important role of nighttime compression in breast cancer-related lymphedema treatment.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33942.
    PubMed    


  8. MCNEELY ML, Dolgoy ND, Rafn BS, Ghosh S, et al
    Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trial.
    Cancer. 2021 Oct 6. doi: 10.1002/cncr.33943.
    PubMed     Abstract available


  9. FALKSON CI
    Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33898.
    PubMed    


  10. OKE O, Niu J, Chavez-MacGregor M, Zhao H, et al
    Adjuvant tamoxifen adherence in men with early-stage breast cancer.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33899.
    PubMed     Abstract available


    September 2021
  11. TAMI-MAURY IM, Liao Y, Rangel ML, Gatus LA, et al
    Active living after cancer: Adaptation and evaluation of a community-based physical activity program for minority and medically underserved breast cancer survivors.
    Cancer. 2021 Sep 23. doi: 10.1002/cncr.33904.
    PubMed     Abstract available


  12. PLASCAK JJ, Rundle AG, Xu X, Mooney SJ, et al
    Associations between neighborhood disinvestment and breast cancer outcomes within a populous state registry.
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33900.
    PubMed     Abstract available



  13. Erratum to "Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis".
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33816.
    PubMed    


    August 2021
  14. FEDEWA SA, Cotter MM, Wehling KA, Wysocki K, et al
    Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.
    Cancer. 2021 Aug 26. doi: 10.1002/cncr.33859.
    PubMed     Abstract available


  15. HENDRICK RE, Monticciolo DL, Biggs KW, Malak SF, et al
    Age distributions of breast cancer diagnosis and mortality by race and ethnicity in US Women.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33846.
    PubMed     Abstract available


  16. SEEWALDT VL, Bernstein L
    The perils of generalization: Rethinking breast cancer screening guidelines for young women of color.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33840.
    PubMed    


  17. YAFFE MJ
    Looking at breast cancer through the ethnic and racial lens-one size definitely does not fit all.
    Cancer. 2021 Aug 24. doi: 10.1002/cncr.33841.
    PubMed     Abstract available


  18. HENDERSON V, Ganschow P, Wang C, Hoskins KF, et al
    Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
    Cancer. 2021 Aug 23. doi: 10.1002/cncr.33867.
    PubMed    


  19. AOKI RF, Uong SP, Gomez SL, Alexeeff SE, et al
    Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California.
    Cancer. 2021 Aug 20. doi: 10.1002/cncr.33861.
    PubMed     Abstract available


  20. NYROP KA, O'Hare EA, Teal R, Stein K, et al
    Person-centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity.
    Cancer. 2021 Aug 10. doi: 10.1002/cncr.33843.
    PubMed     Abstract available


  21. WOLDEAMANUEL YW, Blayney DW, Jo B, Fisher SE, et al
    Headache outcomes of a sleep behavioral intervention in breast cancer survivors: Secondary analysis of a randomized clinical trial.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33844.
    PubMed     Abstract available


  22. NOWAKOWSKA MK, Lei X, Thompson MT, Shaitelman SF, et al
    Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
    Cancer. 2021 Aug 3. doi: 10.1002/cncr.33797.
    PubMed     Abstract available


  23. PRINTZ C
    Mindfulness meditation helps younger breast cancer survivors.
    Cancer. 2021;127:2607.
    PubMed    


    July 2021
  24. ROBERTS SA, Gillespie TC, Shui AM, Brunelle CL, et al
    Weight loss does not decrease risk of breast cancer-related arm lymphedema.
    Cancer. 2021 Jul 27. doi: 10.1002/cncr.33819.
    PubMed     Abstract available


  25. ZHAO F, Henderson TO, Cipriano TM, Copley BL, et al
    The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33798.
    PubMed     Abstract available


  26. POTEAT TC, Adams MA, Malone J, Geffen S, et al
    Delays in breast cancer care by race and sexual orientation: Results from a national survey with diverse women in the United States.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33629.
    PubMed     Abstract available


  27. FAN Q, Yao XA, Han X
    Spatial variation and disparity in female breast cancer relative survival in the United States.
    Cancer. 2021 Jul 15. doi: 10.1002/cncr.33801.
    PubMed     Abstract available


  28. KURIAN AW, Hughes E, Simmons T, Bernhisel R, et al
    Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Cancer. 2021 Jul 6. doi: 10.1002/cncr.33767.
    PubMed     Abstract available


    June 2021
  29. GREER AC, Lanes A, Poorvu PD, Kennedy P, et al
    The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33601.
    PubMed     Abstract available


  30. BROWN JC, Sarwer DB, Troxel AB, Sturgeon K, et al
    A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33752.
    PubMed     Abstract available


  31. RENTSCHER KE, Zhao X, Small BJ, Cohen HJ, et al
    Loneliness and mental health during the COVID-19 pandemic in older breast cancer survivors and noncancer controls.
    Cancer. 2021 Jun 23. doi: 10.1002/cncr.33687.
    PubMed     Abstract available


  32. LYNCE F, Blackburn MJ, Zhuo R, Gallagher C, et al
    Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33620.
    PubMed     Abstract available


  33. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available


  34. PRINTZ C
    Female breast cancer most commonly diagnosed cancer globally.
    Cancer. 2021;127:1952-1953.
    PubMed    


  35. PRINTZ C
    Some patients with postmenopausal breast cancer can avoid adjuvant chemotherapy: Data indicate that some postmenopausal women with breast cancer can safely skip adjuvant chemotherapy.
    Cancer. 2021;127:1951-1952.
    PubMed    


  36. WHITE DP, Kurian AW, Stevens JL, Liu B, et al
    Receipt of guideline-concordant care among young adult women with breast cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33652.
    PubMed     Abstract available


  37. MCCARTHY AM, Ehsan S, Appel S, Welch M, et al
    Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33661.
    PubMed     Abstract available


    May 2021
  38. DHAKAL A, Falkson C, O'Regan RM
    Adjuvant cyclin-dependent kinase 4/6 inhibition in hormone receptor-positive breast cancer: One Monarch to rule them all?
    Cancer. 2021 May 28. doi: 10.1002/cncr.33650.
    PubMed     Abstract available


  39. SUNG H, Freedman RA, Siegel RL, Hyun N, et al
    Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
    Cancer. 2021 May 18. doi: 10.1002/cncr.33602.
    PubMed     Abstract available


  40. MATTHYS MB, Dempsey AM, Melisko ME, Dreher N, et al
    Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
    Cancer. 2021 May 6. doi: 10.1002/cncr.33496.
    PubMed     Abstract available


  41. FARVID MS, Spence ND, Rosner BA, Chen WY, et al
    Consumption of sugar-sweetened and artificially sweetened beverages and breast cancer survival.
    Cancer. 2021 May 4. doi: 10.1002/cncr.33461.
    PubMed     Abstract available


    April 2021
  42. DI MEGLIO A, Gbenou AS, Martin E, Pistilli B, et al
    Unhealthy behaviors after breast cancer: Capitalizing on a teachable moment to promote lifestyle improvements.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33565.
    PubMed     Abstract available


  43. SELLA T, Poorvu PD, Ruddy KJ, Gelber SI, et al
    Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33596.
    PubMed     Abstract available


  44. TAYLOR CE, Meisel JL
    We have to talk about it: Bringing fertility into the conversation for young women with breast cancer.
    Cancer. 2021 Apr 22. doi: 10.1002/cncr.33595.
    PubMed    


  45. ADRADA BE, Candelaria R, Moulder S, Thompson A, et al
    Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
    Cancer. 2021 Apr 20. doi: 10.1002/cncr.33604.
    PubMed     Abstract available


  46. STANGL S, Rauch S, Rauh J, Meyer M, et al
    Disparities in accessibility to evidence-based breast cancer care facilities by rural and urban areas in Bavaria, Germany.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33493.
    PubMed     Abstract available


  47. CORSO G, Maisonneuve P, Veronesi P
    Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast-conserving surgery?
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33550.
    PubMed    


  48. TRINGALE KR, Berger ER, Heerdt AS, Braunstein LZ, et al
    Reply to Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast-conserving surgery?
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33551.
    PubMed    


  49. HENDERSON V, Chukwudozie IB, Comer-Hagans D, Coffey V, et al
    Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525.
    PubMed     Abstract available


  50. SADIGH G, Gray RJ, Sparano JA, Yanez B, et al
    Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33527.
    PubMed     Abstract available


  51. CONNOR AE, Schmaltz CL, Jackson-Thompson J, Visvanathan K, et al
    Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33530.
    PubMed     Abstract available


    March 2021
  52. TAMIRISA N, Lin H, Shen Y, Shaitelman SF, et al
    Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-a National Cancer Database analysis.
    Cancer. 2021 Mar 18. doi: 10.1002/cncr.33489.
    PubMed     Abstract available


  53. FAN R, Chen Y, Nechuta S, Cai H, et al
    Prediction models for breast cancer prognosis among Asian women.
    Cancer. 2021 Mar 11. doi: 10.1002/cncr.33425.
    PubMed     Abstract available


    February 2021
  54. NYANTE SJ, Benefield TS, Kuzmiak CM, Earnhardt K, et al
    Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Cancer. 2021 Feb 26. doi: 10.1002/cncr.33460.
    PubMed     Abstract available


  55. EMERSON MA, Achacoso NS, Benefield HC, Troester MA, et al
    Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaska Native breast cancer survivors.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33423.
    PubMed     Abstract available


  56. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed     Abstract available


  57. OBENG-GYASI S, Timsina LR, Bhattacharyya O, Fisher CS, et al
    Bankruptcy among insured patients with surgical breast cancer: Who is at risk?
    Cancer. 2021 Feb 19. doi: 10.1002/cncr.33468.
    PubMed     Abstract available


  58. BOWER JE, Ganz PA, Irwin MR, Cole SW, et al
    Do all patients with cancer experience fatigue? a longitudinal study of fatigue trajectories in women with breast cancer.
    Cancer. 2021 Feb 19. doi: 10.1002/cncr.33327.
    PubMed     Abstract available


  59. PRINTZ C
    Breast cancer screening for women in their 40s reduces mortality.
    Cancer. 2021;127:497.
    PubMed    


  60. SIMON MS, Hastert TA, Barac A, Banack HR, et al
    Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Cancer. 2021;127:598-608.
    PubMed     Abstract available


  61. NABI J, Tully KH, Cole AP, Marchese M, et al
    Access denied: The relationship between patient insurance status and access to high-volume hospitals.
    Cancer. 2021;127:577-585.
    PubMed     Abstract available


  62. OWUSU C, Nock NL, Feuntes V, Margevicius S, et al
    IMPROVE, a community-based exercise intervention versus support group to improve functional and health outcomes among older African American and Non-Hispanic White breast cancer survivors from diverse socioeconomic backgrounds: Recruitment strategies
    Cancer. 2021 Feb 4. doi: 10.1002/cncr.33430.
    PubMed     Abstract available


    January 2021
  63. REEDER-HAYES KE, Mayer SE, Lund JL
    Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer.
    Cancer. 2021 Jan 28. doi: 10.1002/cncr.33367.
    PubMed     Abstract available


  64. TRINGALE KR, Berger ER, Sevilimedu V, Wen HY, et al
    Breast conservation among older patients with early-stage breast cancer: Locoregional recurrence following adjuvant radiation or hormonal therapy.
    Cancer. 2021 Jan 26. doi: 10.1002/cncr.33422.
    PubMed     Abstract available


  65. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed     Abstract available


  66. PRINTZ C
    Drug shows significant early promise in early, high-risk, HR-positive, HER2-negative breast cancer: Interim data indicate that adding abemaciclib to hormonal therapy reduces recurrence risk.
    Cancer. 2021;127:169-170.
    PubMed    


    December 2020
  67. KNAPP GC, Tansley G, Olasehinde O, Wuraola F, et al
    Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study.
    Cancer. 2020 Dec 28. doi: 10.1002/cncr.33394.
    PubMed     Abstract available


  68. SHAO D, Zhang H, Cui N, Sun J, et al
    The efficacy and mechanisms of a guided self-help intervention based on mindfulness in patients with breast cancer: A randomized controlled trial.
    Cancer. 2020 Dec 17. doi: 10.1002/cncr.33381.
    PubMed     Abstract available


  69. PRINTZ C
    Early breast cancer screening in childhood cancer survivors treated with chest radiation may reduce deaths by more than 50.
    Cancer. 2020;126:5197.
    PubMed    


  70. SEAH DS, Leone JP, Openshaw TH, Scott SM, et al
    Perceptions of patients with early stage breast cancer toward research biopsies.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33371.
    PubMed     Abstract available


  71. LEONE JP, Cole BF, Regan MM, Thurlimann B, et al
    Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
    Cancer. 2020 Dec 8. doi: 10.1002/cncr.33318.
    PubMed     Abstract available


  72. NYROP KA, Damone EM, Deal AM, Carey LA, et al
    Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer.
    Cancer. 2020 Dec 7. doi: 10.1002/cncr.33288.
    PubMed     Abstract available


  73. TAYLOR CE, Meisel JL
    Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer.
    Cancer. 2020 Dec 7. doi: 10.1002/cncr.33290.
    PubMed    


  74. POORVU PD, Gelber SI, Zheng Y, Ruddy KJ, et al
    Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33342.
    PubMed     Abstract available


  75. MOHL A, Orban E, Jung AY, Behrens S, et al
    Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study.
    Cancer. 2020 Dec 1. doi: 10.1002/cncr.33363.
    PubMed     Abstract available


    November 2020
  76. PARK J, Rodriguez JL, O'Brien KM, Nichols HB, et al
    Health-related quality of life outcomes among breast cancer survivors.
    Cancer. 2020 Nov 25. doi: 10.1002/cncr.33348.
    PubMed     Abstract available


  77. NYROP KA, Deal AM, Chen YT, Reeve BB, et al
    Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
    Cancer. 2020 Nov 20. doi: 10.1002/cncr.33329.
    PubMed     Abstract available


  78. BERRIAN JL, Liu Y, Lian M, Schmaltz CL, et al
    Relationship between insurance status and outcomes for patients with breast cancer in Missouri.
    Cancer. 2020 Nov 17. doi: 10.1002/cncr.33330.
    PubMed     Abstract available


  79. FAYANJU OM, Ren Y, Stashko I, Power S, et al
    Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.
    Cancer. 2020 Nov 11. doi: 10.1002/cncr.33310.
    PubMed     Abstract available


  80. DURAND MA, Yen RW, O'Malley AJ, Schubbe D, et al
    What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata.
    Cancer. 2020 Nov 10. doi: 10.1002/cncr.33248.
    PubMed     Abstract available


  81. DESANTIS CE, Siegel RL
    The importance of comprehensive data and statistical testing in the interpretation of breast cancer incidence trends.
    Cancer. 2020 Nov 10. doi: 10.1002/cncr.33263.
    PubMed    


  82. DESAI NV, Yadav S, Batalini F, Couch FJ, et al
    Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk-based testing of those older than 60 years.
    Cancer. 2020 Nov 4. doi: 10.1002/cncr.33305.
    PubMed     Abstract available


  83. CHU QD, Li T, Hsieh MC, Yi Y, et al
    Positive impact of the Patient Protection and Affordable Care Act Medicaid expansion on Louisiana women with breast cancer.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33265.
    PubMed     Abstract available


  84. SEEWALDT VL
    Time for action: The Patient Protection and Affordable Care Act Medicaid expansion significantly improves breast cancer care for women in Louisiana.
    Cancer. 2020 Nov 3. doi: 10.1002/cncr.33264.
    PubMed    


    October 2020
  85. WILLIAMS CP, Gallagher KD, Deehr K, Aswani MS, et al
    Quantifying treatment preferences and their association with financial toxicity in women with breast cancer.
    Cancer. 2020 Oct 27. doi: 10.1002/cncr.33287.
    PubMed     Abstract available


  86. PASKETT ED, Le-Rademacher J, Oliveri JM, Liu H, et al
    A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance).
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33183.
    PubMed     Abstract available


  87. NAUGHTON MJ, Liu H, Seisler DK, Le-Rademacher J, et al
    Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.
    Cancer. 2020 Oct 20. doi: 10.1002/cncr.33184.
    PubMed     Abstract available


  88. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed     Abstract available


    September 2020
  89. GREENE N, Malone J, Adams MA, Dean LT, et al
    "This is some mess right here": Exploring interactions between Black sexual minority women and health care providers for breast cancer screening and care.
    Cancer. 2020 Sep 29. doi: 10.1002/cncr.33219.
    PubMed     Abstract available


  90. EMERSON MA, Golightly YM, Aiello AE, Reeder-Hayes KE, et al
    Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women.
    Cancer. 2020 Sep 21. doi: 10.1002/cncr.33121.
    PubMed     Abstract available


  91. PRINTZ C
    TAILORx study finds early, abrupt cognitive decline among patients with breast cancer.
    Cancer. 2020;126:4083.
    PubMed    


    June 2020

  92. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors.
    Cancer. 2020;126:2566-2570.
    PubMed     Abstract available


    May 2020
  93. HENLEY SJ, Thomas CC, Lewis DR, Ward EM, et al
    Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.
    Cancer. 2020;126:2250-2266.
    PubMed     Abstract available


    April 2020
  94. MAHORTER SS, Knerr S, Bowles EJA, Wernli KJ, et al
    Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial.
    Cancer. 2020;126:1614-1621.
    PubMed     Abstract available


    November 2019
  95. RAMIREZ AG, Choi BY, Munoz E, Perez A, et al
    Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32626.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: